Your browser doesn't support javascript.
loading
CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo.
Israël, Laura; Glück, Anton; Berger, Marjorie; Coral, Marine; Ceci, Melanie; Unterreiner, Adeline; Rubert, Joëlle; Bardet, Maureen; Ginster, Stefanie; Golding-Ochsenbein, Alexandra M; Martin, Kea; Hoyler, Thomas; Calzascia, Thomas; Wieczorek, Grazyna; Hillenbrand, Rainer; Ferretti, Stéphane; Ferrero, Enrico; Bornancin, Frédéric.
Afiliação
  • Israël L; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Glück A; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Berger M; Oncology, NIBR, Novartis Campus, Basel, Switzerland.
  • Coral M; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Ceci M; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Unterreiner A; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Rubert J; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Bardet M; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Ginster S; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Golding-Ochsenbein AM; Chemical Biology & Therapeutics, NIBR, Novartis Campus, Basel, Switzerland.
  • Martin K; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Hoyler T; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Calzascia T; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Wieczorek G; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Hillenbrand R; BioMarker Development, Novartis Pharma AG, Novartis Campus, Basel, Switzerland.
  • Ferretti S; Oncology, NIBR, Novartis Campus, Basel, Switzerland.
  • Ferrero E; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland.
  • Bornancin F; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for BioMedical Research (NIBR), Novartis Campus, Basel, Switzerland. frederic.bornancin@novartis.com.
Oncogenesis ; 10(4): 32, 2021 Apr 06.
Article em En | MEDLINE | ID: mdl-33824280
ABSTRACT
CARD-CC complexes involving BCL10 and MALT1 are major cellular signaling hubs. They govern NF-κB activation through their scaffolding properties as well as MALT1 paracaspase function, which cleaves substrates involved in NF-κB regulation. In human lymphocytes, gain-of-function defects in this pathway lead to lymphoproliferative disorders. CARD10, the prototypical CARD-CC protein in non-hematopoietic cells, is overexpressed in several cancers and has been associated with poor prognosis. However, regulation of CARD10 remains poorly understood. Here, we identified CARD10 as the first MALT1 substrate in non-hematopoietic cells and showed that CARD10 cleavage by MALT1 at R587 dampens its capacity to activate NF-κB. Preventing CARD10 cleavage in the lung tumor A549 cell line increased basal levels of IL-6 and extracellular matrix components in vitro, and led to increased tumor growth in a mouse xenograft model, suggesting that CARD10 cleavage by MALT1 might be a built-in mechanism controlling tumorigenicity.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article